Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

Delayed Data
As of Apr 29
 -1.49 / -5.45%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 40.00, with a high estimate of 65.00 and a low estimate of 23.00. The median estimate represents a +54.74% increase from the last price of 25.85.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Hold stock in Acorda Therapeutics Inc. This rating has held steady since April, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -240.47%
Growthannually -30.17%


Growthquarterly 9.32%
Growthannually 4.59%
Key to the earnings and sales forecast charts.